May & Baker Nigeria Plc. operates in the Medicinals and botanicals sector.
In addition to historical fundamental analyses, the complete report available to purchase compares May & Baker Nigeria Plc. with three other
pharmaceutical manufacturers in Africa:
sales of 70.35 million Dinar [US$22.95 million]
Societe Adwya SA
(95.34 million Dinar [US$31.10 million]
of which 57%
was Pharmacy), and
Fidson Healthcare Limited
(14.06 billion Naira [US$45.97 million]
May & Baker Nigeria Plc. reported sales of 9.35 billion Naira (US$30.58 million)
December of 2017.
increase of 10.4%
versus 2016, when the company's sales were 8.47 billion Naira.
Sales at May & Baker Nigeria Plc. have increased during each of the previous five years
(and since 2012, sales have increased a total of 65%).